ImmunoMolecular Therapeutics, LLC;The Regents of the University of Colorado, a body corporate
发明人:
Steve Orndorff,Aaron Michels
申请号：
US16357397
公开号：
US20190262301A1
申请日:
2019.03.19
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Compounds and compositions useful in methods of treating, ameliorating, or inhibiting the development of autoimmune diseases or Celiac disease by modulating the binding of DQ8 MHC class II molecules to antigenic peptides or fragments of antigenic peptides.
